We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

121 hedge funds and large institutions have $708M invested in Taro Pharmaceutical Industries Ltd. in 2015 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 41 increasing their positions, 34 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 16

21% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 34

14% more funds holding

Funds holding: 106 → 121 (+15)

3% more capital invested

Capital invested by funds: $686M → $708M (+$21.9M)

27% less funds holding in top 10

Funds holding in top 10: 11 → 8 (-3)

76% less call options, than puts

Call options by funds: $3.66M | Put options by funds: $15.3M

Holders
121
Holders Change
+15
Holders Change %
+14.15%
% of All Funds
3.38%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.22%
New
31
Increased
41
Reduced
34
Closed
16
Calls
$3.66M
Puts
$15.3M
Net Calls
-$11.7M
Net Calls Change
-$14.6M

Top Buyers

1
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$40.5M
2
FIM
Freedom Investment Management
Connecticut
+$27.5M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$10.9M
4
KA
Kerrisdale Advisers
Florida
+$10.8M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.4M

Top Sellers

1
RCM
Raging Capital Management
New Jersey
-$37.8M
2
ICM
ISZO Capital Management
New York
-$16.4M
3
HMC
Harvard Management Company
Massachusetts
-$5.03M
4
Millennium Management
Millennium Management
New York
-$4.61M
5
AP
AHL Partners
United Kingdom
-$4.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIIMS
26
Analyst IMS Investment Management Services
Israel
$4.71M -$16.1K -115 -0.3%
FL
27
Fort LP
Maryland
$4.54M +$4.44M +31,764 New
JAM
28
Jupiter Asset Management
United Kingdom
$4.29M – – –
RFC
29
Russell Frank Company
Washington
$4.23M +$342K +2,445 +9%
Marshall Wace
30
Marshall Wace
United Kingdom
$4.21M -$2.37M -16,926 -36%
AllianceBernstein
31
AllianceBernstein
Tennessee
$3.94M – – –
New York State Common Retirement Fund
32
New York State Common Retirement Fund
New York
$3.92M – – –
SGA
33
Strategic Global Advisors
California
$3.68M -$2.96M -21,177 -45%
Ohio Public Employees Retirement System (OPERS)
34
Ohio Public Employees Retirement System (OPERS)
Ohio
$3.37M -$218K -1,560 -6%
CHAM
35
Clear Harbor Asset Management
Connecticut
$3.32M +$605K +4,330 +23%
CIBC Asset Management
36
CIBC Asset Management
Ontario, Canada
$3.13M -$1.44M -10,297 -32%
CC
37
Carrhae Capital
United Kingdom
$3.04M -$97.9K -700 -3%
SLG
38
Stanley-Laman Group
Pennsylvania
$3.01M -$294K -2,100 -9%
Deutsche Bank
39
Deutsche Bank
Germany
$2.94M -$1.25M -8,952 -30%
AAM
40
Advisors Asset Management
Colorado
$2.91M +$502K +3,589 +21%
JAM
41
JW Asset Management
Florida
$2.9M -$4.16M -29,738 -59%
PG
42
PEAK6 Group
Illinois
$2.75M +$957K +6,844 +55%
Macquarie Group
43
Macquarie Group
Australia
$2.71M +$1.02M +7,261 +62%
PAM
44
Panagora Asset Management
Massachusetts
$2.55M +$660K +4,717 +36%
HHC
45
Hutchin Hill Capital
New York
$2.42M +$769K +5,500 +48%
FIM
46
Freedom Investment Management
Connecticut
$2.11M +$27.5M +196,520 +8,734%
Northern Trust
47
Northern Trust
Illinois
$1.7M +$116K +830 +8%
Two Sigma Investments
48
Two Sigma Investments
New York
$1.67M +$61.5K +440 +4%
CCMG
49
Clark Capital Management Group
Pennsylvania
$1.66M +$319K +2,280 +24%
Arrowstreet Capital
50
Arrowstreet Capital
Massachusetts
$1.63M +$30.9K +221 +2%
1
2
3 4 5

TARO Hedge Fund Activity: Q3 2015 in Review

121 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q3 2015, worth a combined $708M — up 3.2% from $686M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new TARO positions and 16 closed out — a net gain of 15 holders — while 41 added to existing stakes and 34 trimmed.

The largest buyer was Schroder Investment Management Group, adding an estimated $40.5M. The largest seller was Raging Capital Management, exiting entirely with an estimated $37.8M sold.

  • 121 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q3 2015, up from 106 in Q2 2015.
  • Funds reported $708M of Taro Pharmaceutical Industries Ltd. stock for Q3 2015, up 3.2% quarter-over-quarter.
  • 31 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q3 2015 and 16 closed out, a net change of +15 holders.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q3 2015 was Schroder Investment Management Group, an estimated $40.5M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q3 2015 was Raging Capital Management, an estimated $37.8M sold.

Based on aggregated 13F filings for Q3 2015.